Abstract
Liver fibrosis occurs in most types of chronic liver diseases and is characterized by excessive accumulation of extracellular matrix proteins, leading to disruption of tissue function and eventually organ failure. Transforming growth factor (TGF)-β represents an important pro-fibrogenic factor and aberrant TGF-β action has been implicated in many disease processes of the liver. Endoglin is a TGF-β co-receptor expressed mainly in endothelial cells that has been shown to differentially regulates TGF-β signal transduction by inhibiting ALK5-Smad2/3 signalling and augmenting ALK1-Smad1/5 signalling. Recent reports demonstrating upregulation of endoglin expression in pro-fibrogenic cell types such as scleroderma fibroblasts and hepatic stellate cells have led to studies exploring the potential involvement of this TGF-β co-receptor in organ fibrosis. A recent article by Meurer and colleagues now shows that endoglin expression is increased in transdifferentiating hepatic stellate cells in vitro and in two different models (carbon tetrachloride intoxication and bile duct ligation) of liver fibrosis in vivo. Moreover, they show that endoglin overexpression in hepatic stellate cells is associated with enhanced TGF-β-driven Smad1/5 phosphorylation and α-smooth muscle actin production without altering Smad2/3 signaling. These findings suggest that endoglin may play an important role in hepatic fibrosis by altering the balance of TGF-β signaling via the ALK1-Smad1/5 and ALK-Smad2/3 pathways and raise the possibility that targeting endoglin expression in transdifferentiating hepatic stellate cells may represent a novel therapeutic strategy for the treatment of liver fibrosis.
References
Bellon T, Corbi A, Lastres P, Cales C, Cebrian M, Vera S, Cheifetz S, Massague J, Letarte M, Bernabeu C (1993) Identification and expression of two forms of the human transforming growth factor-β-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 23:2340–2345
Bernabeu C, Lopez-Novoa JM, Quintanilla M (2009) The emerging role of TGF-β superfamily co-receptors in cancer. Biochim Biophys Acta 1792:954–973
Bernabeu C, Blanco FJ, Langa C, Garrido-Martin E, Botella L (2010) Involvement of the TGF-β superfamily signalling pathway in hereditary haemorrhagic telangiectasia. J Appl Biomed 8:169–177
Biernacka A, Dobaczewski M, Frangogiannis NG (2011) TGF-β signaling in fibrosis. Growth Factors 29:196–202
Chen K, Mehta JL, Li D, Joseph L, Joseph J (2004) Transforming growth factor β receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res 95:1167–1173
Clemente M, Nunez O, Lorente R, Rincon D, Matilla A, Salcedo M, Catalina MV, Ripoll C, Iacono OL, Banares R et al (2006) Increased intrahepatic and circulating levels of endoglin, a TGF-β1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis. J Viral Hepat 13:625–632
Daly AC, Randall RA, Hill CS (2008) Transforming growth factor β-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol Cell Biol 28:6889–6902
Dooley S, Ten Dijke P (2011) TGF-β in progression of liver disease. Cell Tissue Res. doi:10.1007/s00441-011-1246-y
Finnson KW, Parker WL, ten Dijke P, Thorikay M, Philip A (2008) ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J Bone Miner Res 23:896–906
Finnson KW, Parker WL, Chi Y, Hoemann C, Goldring MB, Antoniou J, Philip A (2010) Endoglin differentially regulates TGF-β-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthr Cartil 18:1518–1527
Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF-β/ALK5 signaling. Mol Cell 12:817–828
Guerrero-Esteo M, Sanchez-Elsner T, Letamendia A, Bernabeu C (2002) Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-β receptors I and II. J Biol Chem 277:29197–29209
Hawinkels LJ, Kuiper P, Wiercinska E, Verspaget HW, Liu Z, Pardali E, Sier CF, Ten Dijke P (2010) Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis. Cancer Res 70:4141–4150
Koleva RI, Conley BA, Romero D, Riley KS, Marto JA, Lux A, Vary CP (2006) Endoglin structure and function: determinants of endoglin phosphorylation by transforming growth factor-β receptors. J Biol Chem 281(35):25110–25123
Kruse JJ, Floot BG, te Poele JA, Russell NS, Stewart FA (2009) Radiation-induced activation of TGF-β signaling pathways in relation to vascular damage in mouse kidneys. Radiat Res 171:188–197
Leask A, Abraham DJ, Finlay DR, Holmes A, Pennington D, Shi-Wen X, Chen Y, Venstrom K, Dou X, Ponticos M et al (2002) Dysregulation of transforming growth factor β signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum 46:1857–1865
Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P (2004) Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J 23:4018–4028
Massague J, Gomis RR (2006) The logic of TGF-β signaling. FEBS Lett 580:2811–2820
Meurer SK, Tihaa L, Lahme B, Gressner AM, Weiskirchen R (2005) Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor-β receptor signaling. J Biol Chem 280:3078–3087
Meurer SK, Tihaa L, Borkham-Kamphorst E, Weiskirchen R (2011) Expression and functional analysis of endoglin in isolated liver cells and its involvement in fibrogenic Smad signalling. Cell Signal 23:683–699
Morris E, Chrobak I, Bujor A, Hant F, Mummery C, Ten Dijke P, Trojanowska M (2011) Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts. J Cell Physiol
Pérez-Barriocanal F, Docherty N, Arévalo M, Düwel A, Rivas-Elena J, González-Buitrago J, Esteller A, Bernabeu C, López-Novoal J (2011) Endoglin upregulation in the liver after bile duct ligation in rats. Open Gastroenterol J 5:1–9
Preativatanyou K, Honsawek S, Chongsrisawat V, Vejchapipat P, Theamboonlers A, Poovorawan Y (2010) Correlation of circulating endoglin with clinical outcome in biliary atresia. Eur J Pediatr Surg 20:237–241
Prieto M, Rodriguez-Pena AB, Duwel A, Rivas JV, Docherty N, Perez-Barriocanal F, Arevalo M, Vary CP, Bernabeu C, Lopez-Novoa JM, Eleno N (2005) Temporal changes in renal endoglin and TGF-β1 expression following ureteral obstruction in rats. J Physiol Biochem 61:457–467
Quintanilla M, Ramirez JR, Perez-Gomez E, Romero D, Velasco B, Letarte M, Lopez-Novoa JM, Bernabeu C (2003) Expression of the TGF-β coreceptor endoglin in epidermal keratinocytes and its dual role in multistage mouse skin carcinogenesis. Oncogene 22:5976–5985
Ray BN, Lee NY, How T, Blobe GC (2010) ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration. Carcinogenesis 31(3):435–441
Rodriguez-Pena A, Prieto M, Duwel A, Rivas JV, Eleno N, Perez-Barriocanal F, Arevalo M, Smith JD, Vary CP, Bernabeu C, Lopez-Novoa JM (2001) Up-regulation of endoglin, a TGF-β-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction. Nephrol Dial Transplant 16(Suppl 1):34–39
Rodriguez-Pena A, Eleno N, Duwell A, Arevalo M, Perez-Barriocanal F, Flores O, Docherty N, Bernabeu C, Letarte M, Lopez-Novoa JM (2002) Endoglin upregulation during experimental renal interstitial fibrosis in mice. Hypertension 40:713–720
Roy-Chaudhury P, Simpson JG, Power DA (1997) Endoglin, a transforming growth factor-β-binding protein, is upregulated in chronic progressive renal disease. Exp Nephrol 5:55–60
Sadlier DM, Connolly SB, Kieran NE, Roxburgh S, Brazil DP, Kairaitis L, Wang Y, Harris DC, Doran P, Brady HR (2004) Sequential extracellular matrix-focused and baited-global cluster analysis of serial transcriptomic profiles identifies candidate modulators of renal tubulointerstitial fibrosis in murine adriamycin-induced nephropathy. J Biol Chem 279:29670–29680
Santibanez JF, Quintanilla M, Bernabeu C (2011) TGF-β/TGF-β receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 121:233–251
Scharpfenecker M, Floot B, Russell NS, Ten Dijke P, Stewart FA (2009) Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys. Radiother Oncol 92:484–491
Schmierer B, Hill CS (2007) TGFβ-Smad signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8:970–982
Shyu KG, Wang BW, Chen WJ, Kuan P, Hung CR (2010) Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-β1 in cultured cardiac fibroblasts. Eur J Heart Fail 12:219–226
Velasco S, Alvarez-Munoz P, Pericacho M, Ten Dijke P, Bernabeu C, Lopez-Novoa JM, Rodriguez-Barbero A (2008) L- and S-endoglin differentially modulate TGF-β1 signaling mediated by ALK1 and ALK5 in L6E9 myoblasts. J Cell Sci 121:913–919
Yagmur E, Rizk M, Stanzel S, Hellerbrand C, Lammert F, Trautwein C, Wasmuth HE, Gressner AM (2007) Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma. Eur J Gastroenterol Hepatol 19:755–761
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finnson, K.W., Philip, A. Endoglin in liver fibrosis. J. Cell Commun. Signal. 6, 1–4 (2012). https://doi.org/10.1007/s12079-011-0154-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-011-0154-y